Full list of author information is available at the end of the articledrugs and medical devices (designated “registration trials” in the present article). The Japanese infrastructure for registration trials has improved since the introduction of the Good Clinical Practice (GCP) standard in 1997 and plans for the promotion of registration trials by the is now widely recognized not only for practical pursuit, but also for quality assurance in these trials. On the other hand, investigator-initiated health research is conducted based on Japanese governmental guidelines
Though Japan has surpassed South Korea in terms of research and development (R&D) in the area of...
In Japan, clinical trials aimed at new drug/device application (NDA) are regulated by the Pharmaceut...
Research on health and human rights is increasing in Japan, but this trend has never been studied. W...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
The Japanese Ministry of Health, Labour and Welfare (JMHLW) introduced the Clinical Research Law1 in...
This article evaluates the impact of the ICH E9 guideline Statistical Principles for Clinical Trials...
Background:Japanese Clinical Research Act was enacted in April 2017 and this Act covers clinical tri...
Background: Established on 1 June 2005, the University Hospital Medical Information Network Clinical...
Background:In the United States (U.S.), human subject protection regulations, called “Common Rule”, ...
Despite increasing numbers of RCTs done in Japan, existing international databases fail to capture t...
Objective To clarify the impact of Japan’s Clinical Trials Act (CTA), which was enacted in April 201...
<div><p>Objectives</p><p>Despite increasing numbers of RCTs done in Japan, existing international da...
Background : Enforcement of the 2018 Clinical Trials Act (CTA) in Japan resulted in strict and compl...
In April 2018, the Clinical Trials Act pertaining to investigator-initiated clinical trials was pass...
Though Japan has surpassed South Korea in terms of research and development (R&D) in the area of...
In Japan, clinical trials aimed at new drug/device application (NDA) are regulated by the Pharmaceut...
Research on health and human rights is increasing in Japan, but this trend has never been studied. W...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
The Japanese Ministry of Health, Labour and Welfare (JMHLW) introduced the Clinical Research Law1 in...
This article evaluates the impact of the ICH E9 guideline Statistical Principles for Clinical Trials...
Background:Japanese Clinical Research Act was enacted in April 2017 and this Act covers clinical tri...
Background: Established on 1 June 2005, the University Hospital Medical Information Network Clinical...
Background:In the United States (U.S.), human subject protection regulations, called “Common Rule”, ...
Despite increasing numbers of RCTs done in Japan, existing international databases fail to capture t...
Objective To clarify the impact of Japan’s Clinical Trials Act (CTA), which was enacted in April 201...
<div><p>Objectives</p><p>Despite increasing numbers of RCTs done in Japan, existing international da...
Background : Enforcement of the 2018 Clinical Trials Act (CTA) in Japan resulted in strict and compl...
In April 2018, the Clinical Trials Act pertaining to investigator-initiated clinical trials was pass...
Though Japan has surpassed South Korea in terms of research and development (R&D) in the area of...
In Japan, clinical trials aimed at new drug/device application (NDA) are regulated by the Pharmaceut...
Research on health and human rights is increasing in Japan, but this trend has never been studied. W...